STOCK PURCHASE AGREEMENTStock Purchase Agreement • February 6th, 2014 • Forest Laboratories Inc • Pharmaceutical preparations • New York
This Stock Purchase Agreement, dated November 12, 2013 (the “Purchase Agreement”), is by and between A. Robert D. Bailey (“Purchaser”) and Forest Laboratories, Inc., a Delaware corporation (“Seller”).
ASSET PURCHASE AGREEMENT By and between Merck Sharp & Dohme BV and Forest Laboratories Holdings Limited Dated as of November 29, 2013Asset Purchase Agreement • February 6th, 2014 • Forest Laboratories Inc • Pharmaceutical preparations • New York
This Asset Purchase Agreement (this “Agreement”) is made and executed as of November 29, 2013 (the “Execution Date”), by and between Merck Sharp & Dohme BV, a limited liability company (a Besloten Vennootschap) organized and existing under the Laws of the Netherlands (“Seller”), and Forest Laboratories Holdings Limited, an Irish corporation (“Buyer”). Seller and Buyer are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
AMENDED AND RESTATED PATENT AND KNOW-HOW LICENSE AGREEMENTHow License Agreement • February 6th, 2014 • Forest Laboratories Inc • Pharmaceutical preparations • New York
This AMENDED AND RESTATED PATENT AND KNOW-HOW LICENSE AGREEMENT (the “Agreement”) dated this 17th day of December, 2013 (the “Restatement Effective Date”) by and between PIERRE FABRE MÉDICAMENT SAS, a corporation organized under the laws of France and having its principal offices at 45, Place Abel Gance 92100 Boulogne - France (“Pierre Fabre”) and FOREST LABORATORIES HOLDINGS LIMITED, a corporation organized under the laws of the Republic of Ireland and having its principal place of business at Cumberland House, 9th Floor, 1 Victoria Street, Hamilton HM 11, Bermuda(“Forest”) a wholly-owned subsidiary of Forest Laboratories, Inc., a Delaware company having its principal offices at 909 Third Avenue, New York, New York 10022.
LICENSE AGREEMENT By and between Merck Sharp & Dohme BV and Forest Laboratories Holdings Limited Dated as of January 10, 2014License Agreement • February 6th, 2014 • Forest Laboratories Inc • Pharmaceutical preparations • New York
This License Agreement (this “Agreement”) is made and entered into effective as of January 10, 2014 (the “Effective Date”) by and between Merck Sharp & Dohme BV, a limited liability company (a Besloten Vennootschap) organized and existing under the Laws of the Netherlands (“Seller”), and Forest Laboratories Holdings Limited, an entity organized and existing under the Laws of Ireland (“Buyer”). Seller and Buyer are sometimes referred herein individually as a “Party” and collectively as the “Parties.”
SUPPLY AGREEMENT By and between Merck Sharp & Dohme BV and Forest Laboratories Ireland Limited Dated as of January 10, 2014Supply Agreement • February 6th, 2014 • Forest Laboratories Inc • Pharmaceutical preparations • New York
This SUPPLY AGREEMENT (this “Agreement”), effective as of the 10th day of January, 2014 (the “Effective Date”), is made and entered into by and between Merck Sharp & Dohme BV, a limited liability company (a Besloten Vennootschap) organized and existing under the Laws of the Netherlands (“Seller”), and Forest Laboratories Ireland Limited, a corporation organized and existing under the Laws of Ireland (“Buyer”). Seller and Buyer are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
AMENDED AND RESTATED PURCHASE AND SUPPLY AGREEMENTPurchase and Supply Agreement • February 6th, 2014 • Forest Laboratories Inc • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED PURCHASE AND SUPPLY AGREEMENT (this “Agreement”) is made and entered into as of this 17th day of December, 2013 (the “Restatement Effective Date”), by and between PIERRE FABRE MÉDICAMENT SAS, organized under the laws of France having an address of 45, place Abel-Gance, 92654 Boulogne Cedex, France (“Pierre Fabre”), and FOREST LABORATORIES HOLDINGS LIMITED, a corporation organized under the laws of the Republic of Ireland and having an address of Milner House, 18 Parliament Street, Hamilton HM11, Bermuda (“Forest”), a wholly-owned subsidiary of Forest Laboratories, Inc., a Delaware corporation having its principal place of business at 909 Third Avenue, New York, New York 10022.
AMENDED AND RESTATED TRADEMARK LICENSE AGREEMENTTrademark License Agreement • February 6th, 2014 • Forest Laboratories Inc • Pharmaceutical preparations • New York
This Amended and Restated Trademark License Agreement (this “Agreement”) is entered into as of this 17th day of December, 2013 (the “Restatement Effective Date”) by and between Pierre Fabre Médicament s.a.s. organized under the laws of France having an address of 45, place Abel-Gance, 92654 Boulogne cedex, France (“Pierre Fabre”), and Forest laboratories Holding Limited, a corporation organized under the laws of the Republic of Ireland and having its principal place of business at Milner House, 18 Parliament Street, Hamilton HM11, Bermuda (“Forest”), a wholly-owned subsidiary of Forest laboratories, Inc, a Delaware corporation having its principal place of business at 909 Third Avenue, New York, New York 10022, United Sates of America.
